Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress

American Journal of Physiology - Cell Physiology

Volumn 285, Issue 5 54-5, 2003, Pages

  Muro, Silvia ^a   Cui, Xiumin ^a   Gajewski, Christine ^a   Murciano, Juan Carlos ^a   Muzykantov, Vladimir R ^a   Koval, Michael ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Drug delivery; Endocytosis; Lysosomes; Microtubules

Indexed keywords

AMILORIDE; CATALASE; CAVEOLIN; CHLOROQUINE; CLATHRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LIGAND; NANOPARTICLE; NOCODAZOLE;

ACIDIFICATION; ANTIGEN BINDING; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRADATION KINETICS; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; ENZYME ANALYSIS; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LIGAND BINDING; LYSOSOME; NANOTECHNOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0142116193     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00099.2003     Document Type: Article

References (55)

1. Atochina EN, Balyasnikova IV, Danilov SM, Granger DN, Fisher AB, and Muzykantov VR. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. Am J Physiol Lung Cell Mol Physiol 275: L806-L817, 1998.
2. Blackwell JE, Dagia NM, Dickerson JB, Berg EL, and Goetz DJ. Ligand coated nanosphere adhesion to E- and P-selectin under static and flow conditions. Ann Biomed Eng 29: 523-533, 2001.
3. Bloemen PG, Henricks PA, van Bloois L, van den Tweel MC, Bloem AC, Nijkamp FP, Crommelin DJ, and Storm G. Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett 357: 140-144, 1995.
4. Brigger I, Dubernet C, and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54: 631-651, 2002.
5. Broide DH, Humber D, Sullivan S, and Sriramarao P. Inhibition of eosinophil rolling and recruitment in P-selectin-and intracellular adhesion molecule-1-deficient mice. Blood 91: 2847-2856, 1998.
6. Caron E and Hall A. Phagocytosis. In: Endocytosis, edited by Marsh M. Oxford, UK: Oxford University Press, 2001, p. 58-77.
7. Chan CK and Jans DA. Using nuclear targeting signals to enhance non-viral gene transfer. Immunol Cell Biol 80: 119-130, 2002.
8. Chorny M, Fishbein I, Danenberg HD, and Golomb G. Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods. J Control Release 83: 401, 2002.
9. Christofidou-Solomidou M, Pietra GG, Solomides CC, Arguiris E, Harshaw D, Fitzgerald GA, Albelda SM, and Muzykantov VR. Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol 278: L794-L805, 2000.
10. DeMeester SR, Molinari MA, Shiraishi T, Okabayashi K, Manchester JK, Wick MR, Cooper JD, and Patterson GA. Attenuation of rat lung isograft reperfusion injury with a combination of anti-ICAM-1 and anti-beta2 integrin monoclonal antibodies. Transplantation 62: 1477-1485, 1996.
11. Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, and Springer TA. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 111: 3129-3139, 1990.
12. Diamond MS, Staunton DE, Marlin SD, and Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65:961-971, 1991.
13. Doerschuk CM, Quinlan WM, Doyle NA, Bullard DC, Vestweber D, Jones ML, Takei F, Ward PA, and Beaudet AL. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol 157: 4609-4614, 1996.
14. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, and Springer TA. Induction by IL 1 and interferon- gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137: 245-254, 1986.
15. Eng CM, Banikazemi M, Gordon RE, Goldman M, Phelps R, Kim L, Gass A, Winston J, Dikman S, Fallon JT, Brodie S, Stacy CB, Mehta D, Parsons R, Norton K, O'Callaghan M, and Desnick RJ. A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet 68: 711-722, 2001.
16. Fisher AB, Al-Mehdi AB, and Muzykantov V. Activation of endothelial NADPH oxidase as the source of a reactive oxygen species in lung ischemia. Chest 116: 25S-26S, 1999.
17. Heffner JE and Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 140: 531-554, 1989.
18. Hubbard AK and Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 28: 1379-1386, 2000.
19. Johnson-Saliba M and Jans DA. Gene therapy: optimising DNA delivery to the nucleus. Curr Drug Targets 2: 371-399, 2001.
20. Kim CK and Lim SJ. Recent progress in drug delivery systems for anticancer agents. Arch Pharm Res 25: 229-239, 2002.
21. Koval M, Preiter K, Adles C, Stahl PD, and Steinberg TH. Size of IgG-opsonized particles determines macrophage response during internalization. Exp Cell Res 242: 265-273, 1998.
22. Kozower BD, Christofidou-Solomidou M, Sweitzer TD, Muro S, Buerk DG, Solomides CC, Albelda SM, Patterson GA, and Muzykantov VR. Immunotargeting of catalase to the pulmonarv endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol 21: 392-398, 2003.
23. Kumasaka T, Quinlan WM, Doyle NA, Condon TP, Sligh J, Takei F, Beaudet A, Bennett CF, and Doerschuk CM. Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonu-cleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest 97: 2362-2369, 1996.
24. Langer R. Drug delivery. Drugs on target. Science 293: 58-59, 2001.
25. Lin L and Lobel P. Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis. Biochem J 357: 49-55, 2001.
26. Lum H and Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280: C719-C741, 2001.
27. Marsh EW, Leopold PL, Jones NL, and Maxfield FR. Oligomerized transferrin receptors are selectively retained by a lumenal sorting signal in a long-lived endocytic recycling compartment. J Cell Biol 129: 1509-1522, 1995.
28. McIntosh DP, Tan XY, Oh P, and Schnitzer JE. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci USA 99: 1996-2001, 2002.
29. Melis M, Pace E, Siena L, Spatafora M, Tipa A, Profita M, Bonanno A, Vignola AM, Bonsignore G, Mody CH, and Gjomarkaj M. Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. Am J Respir Crit Care Med 167: 1131-1138, 2003.
30. Mu L and Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86: 33-48, 2003.
31. Mukherjee S, Ghosh RN, and Maxfield FR. Endocytosis. Physiol Rev 77: 759-803, 1997.
32. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, and Ward PA. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 142: 1739-1749, 1993.
33. Murciano JC, Muro S, Koniaris L, Christofidou-Solomidou M, Harshaw DW, Albelda SM, Granger DN, Cines DB, and Muzykantov VR. ICAM-directed vascular immunotargeting of anti-thrombotic agents to the endothelial surface. Blood 101: 3977-3984, 2003.
34. Muro S, Wiewrodt R, Thomas AP, Koniaris L, Albelda SM, Muzykantov VR, and Koval M. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci 116: 1599-1609, 2003.
35. Muzykantov VR. Delivery of antioxidant enzyme proteins to the lung. Antioxid Redox Signal 3: 39-62, 2001.
36. Muzykantov VR. Targeting of superoxide dismutase and catalase to vascular endothelium. J Control Release 71: 1-21, 2001.
37. Muzykantov VR, Christofidou-Solomidou M, Balyasnikova I, Harshaw DW, Schultz L, Fisher AB, and Albelda SM. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci USA 96: 2379-2384, 1999.
38. Panes J, Perry MA, Anderson DC, Manning A, Leone B, Cepinskas G, Rosenbloom CL, Miyasaka M, Kvietys PR, and Granger DN. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol Heart Circ Physiol 269: H1955-H1964, 1995.
39. Panyam J, Zhou WZ, Prabha S, Sahoo SK, and Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16: 1217-1226, 2002.
40. Pauly DF, Fraites TJ, Toma C, Bayes HS, Huie ML, Hirschhorn R, Plotz PH, Raben N, Kessler PD, and Byrne BJ. Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease. Hum Gene Ther 12: 527-538, 2001.
41. Polakovic M, Gorner T, Gref R, and Dellacherie E. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J Control Release 60: 169-177, 1999.
42. Poznansky MJ and Juliano RL. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev 36: 277-336, 1984.
43. Predescu D, Predescu S, McQuistan T, and Palade GE. Transcytosis of alphal-acidic glycoprotein in the continuous microvascular endothelium. Proc Natl Acad Sci USA 95: 6175-6180, 1998.
44. Prokop A, Kozlov E, Newman GW, and Newman MJ. Water-based nanoparticulate polymeric system for protein delivery: permeability control and vaccine application. Biotechnol Bioeng 78: 459-466, 2002.
45. Raso V. Immunotargeting intracellular compartments. Anal Biochem 222: 297-304, 1994.
46. Scheel J, Matteoni R, Ludwig T, Hoflack B, and Kreis TE. Microtubule depolymerization inhibits transport of cathepsin D from the Golgi apparatus to lysosomes. J Cell Sci 96: 711-720, 1990.
47. Scherpereel A, Wiewrodt R, Christofidou-Solomidou M, Gervais R, Murciano JC, Albelda SM, and Muzykantov VR. Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting. FASEB J 15: 416-426, 2001.
48. Springer TA. Adhesion receptors of the immune system. Nature 346: 425-434, 1990.
49. Swanson J, Burke E, and Silverstein SC. Tubular lysosomes accompany stimulated pinocytosis in macrophages. J Cell Biol 104: 1217-1222, 1987.
50. Varani J and Ward PA. Mechanisms of endothelial cell injury in acute inflammation. Shock 2: 311-319, 1994.
51. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC, Brandenburger GH, and Wagner WR. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 98: 1-5, 1998.
52. Weiner RE, Sasso DE, Gionfriddo MA, Syrbu SI, Smilowitz HM, Vento J, and Thrall RS. Early detection of bleomycin-induced lung injury in rat using indium-111-labeled antibody directed against intercellular adhesion molecule-1. J Nucl Med 39: 723-728, 1998.
53. Wiewrodt R, Thomas AP, Cipelletti L, Christofidou-Solomidou M, Weitz DA, Feinstein SI, Schaffer D, Albelda SM, Koval M, and Muzykantov VR. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood 99: 912-922, 2002.
54. Wolin MS, Gupte SA, and Oeckler RA. Superoxide in the vascular system. J Vasc Res 39: 191-207, 2002.
55. Yayon A, Cabantchik ZI, and Ginsburg H. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J 3: 2695-2700, 1984.